Drusen, the hallmark lesion of early AMD, contain proteins from the alternative complement pathway including CFH, C3 and its activation products, and terminal pathway components including C5 and the membrane attack complex (MAC) (Mullins et al. 2000; Anderson et al. 2010). This evidence concerns the gene CFH and age-related macular degeneration.